ArticleNature nanotechnology2025

Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes.

Xianguang Ding et al.PubMed ↗Publisher ↗

No numbers read from the abstract.